SMAD3 and glioblastoma: The present study aimed to confirm the functions of Smad2 and Smad3 in GBM cells by transfecting U251 cells with shRNAs to selectively deplete Smad2 and Smad3, and analyzing the proliferative response of the cells to TGFβ2 using a CCK-8 assay.